Hepatocellular carcinoma (HCC) is a complex and heterogeneous tumor with several genomic alterations. There is evidence of aberrant activation of several signaling cascades such as epidermal growth factor receptor (EGFR), Ras/extracellular signal-regulated kinase, phosphoinositol 3-kinase/mammalian
β¦ LIBER β¦
Targeted therapies in control of EMT in carcinoma and fibrosis
β Scribed by Kian-Ngiap Chua; Jing Ma; Jean-Paul Thiery
- Book ID
- 119225521
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 623 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1740-6765
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Molecular targeted therapies in hepatoce
β
Josep M. Llovet; Jordi Bruix
π
Article
π
2008
π
John Wiley and Sons
π
English
β 647 KB
Emerging targeted therapies in scleroder
β
Britta Maurer; Oliver Distler
π
Article
π
2011
π
Elsevier Science
π
English
β 210 KB
Targeted therapies in the treatment of p
β
MarΓa Luz Amador MuΓ±oz; Manuel Hidalgo Medina
π
Article
π
2003
π
Springer Milan
π
Spanish
β 66 KB
Targeted therapies in squamous cell carc
β
Kathryn A. Gold; Ho-Young Lee; Edward S. Kim
π
Article
π
2009
π
John Wiley and Sons
π
English
β 170 KB
π 3 views
## Abstract Head and neck cancer is a challenging disease that is expected to account for greater than 500,000 new cases worldwide in 2008. Toxicity has impeded advances in chemotherapy and radiation for head and neck cancer, and the prognosis for patients with recurrent and/or metastatic disease r
Potentiation of cytotoxic therapies by T
β
Beverly A. Teicher; Sylvia A. Holden; Norman P. Dupuis; Yoshihiro Kakeji; Masahi
π
Article
π
1995
π
Springer US
π
English
β 812 KB
Management of metastatic renal cell carc
β
K. Webber; A. Cooper; H. Kleiven; D. Yip; D. Goldstein
π
Article
π
2011
π
John Wiley and Sons
π
English
β 160 KB